Koenig Sheldon L.

Track

Insider profile

Performance

Overall performance
2.9
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 13% 8.2% 15.1%
Success rate 82% 68% 82%
Transactions
11 18% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -25%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Koenig Sheldon L.'s trades of Esperion Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-18 2026-06-17
S Sale
7,435 -25.5%
55.59
US$1,791,018 		7,435 -25.5% 55.59 US$1,791,018
2026-06-17 2026-06-17
PrS Proposed sale
24,592
449.69
US$946,950 		24,592 449.69 US$946,950
2026-03-18 2026-03-17
S Sale
11,072 +44.3%
167.34
US$545,078 		11,072 +44.3% 167.34 US$545,078
2026-03-17 2026-03-17
PrS Proposed sale
25,578
2.72
US$69,552 		25,578 2.72 US$69,552
2025-12-18 2025-12-17
S Sale
48,244 -3.2%
3.67
US$177,200 		48,244 -3.2% 3.67 US$177,200
2025-12-17 2025-12-17
PrS Proposed sale
48,244
3.67
US$177,200 		48,244 3.67 US$177,200
2025-09-18 2025-09-17
PlS Planned sale
28,427 -1.8%
2.79
US$79,254 		28,427 -1.8% 2.79 US$79,254
2025-09-17 2025-09-17
PrS Proposed sale
28,427
2.79
US$79,240 		28,427 2.79 US$79,240
2025-06-18 2025-06-17
S Sale
30,474 -1.9%
1.11
US$33,796 		30,474 -1.9% 1.11 US$33,796
2025-06-17 2025-06-17
PrS Proposed sale
30,474
1.11
US$33,793 		30,474 1.11 US$33,793
2025-03-19 2025-03-18
S Sale
13,047 -0.8%
1.50
US$19,623 		13,047 -0.8% 1.50 US$19,623
2025-03-18 2025-03-18
PrS Proposed sale
13,047
1.50
US$19,619 		13,047 1.50 US$19,619
2024-12-18 2024-12-17
S Sale
12,447 -1.7%
2.47
US$30,694 		12,447 -1.7% 2.47 US$30,694
2024-12-17 2024-12-17
PrS Proposed sale
12,447
2.47
US$30,698 		12,447 2.47 US$30,698
2024-09-18 2024-09-17
S Sale
14,550 -1.9%
1.80
US$26,132 		14,550 -1.9% 1.80 US$26,132
2024-09-17 2024-09-17
PrS Proposed sale
14,550
1.80
US$26,133 		14,550 1.80 US$26,133
2023-05-10 2023-05-09
B Purchase
20,000 +6.8%
1.26
US$25,192 		20,000 +6.8% 1.26 US$25,192
2023-03-20 2023-03-17
S Sale
6,999 -2.3%
1.78
US$12,479 		6,999 -2.3% 1.78 US$12,479
2023-03-17 2023-03-17
PrS Proposed sale
6,999
1.78
US$12,479 		6,999 1.78 US$12,479
2023-03-08 2023-03-07
PlS Planned sale
5,441 -2.7%
5.06
US$27,510 		5,441 -2.7% 5.06 US$27,510
2023-03-07 2023-03-07
PrS Proposed sale
5,441
5.06
US$27,511 		5,441 5.06 US$27,511
2022-09-20 2022-09-19
PlS Planned sale
3,394 -1.7%
6.94
US$23,548 		3,394 -1.7% 6.94 US$23,548
2022-08-08 2022-08-05
B Purchase
8,606 +4.5%
5.80
US$49,950 		8,606 +4.5% 5.80 US$49,950
2022-06-21 2022-06-17
S Sale
4,552 -2.3%
4.99
US$22,719 		4,552 -2.3% 4.99 US$22,719
2022-03-18 2022-03-17
S Sale
571 -0.3%
4.58
US$2,615 		571 -0.3% 4.58 US$2,615